Reference
NICE. NICE recommends new lung cancer drug pembrolizumab. Internet Document : 2 Dec 2016. Available from: URL: https://www.nice.org.uk/news/article/nice-recommends-new-lung-cancer-drug-pembrolizumab
Rights and permissions
About this article
Cite this article
NICE recommends pembrolizumab for advanced NSCLC. PharmacoEcon Outcomes News 768, 37 (2016). https://doi.org/10.1007/s40274-016-3635-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3635-7